China · Delayed Price · Currency is CNY Autobio Diagnostics Statistics
Total Valuation
SHA:603658 has a market cap or net worth of CNY 21.89 billion. The enterprise value is 20.48 billion.
| Market Cap | 21.89B |
| Enterprise Value | 20.48B |
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
SHA:603658 has 571.42 million shares outstanding. The number of shares has decreased by -0.27% in one year.
| Current Share Class | 571.42M |
| Shares Outstanding | 571.42M |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | +1.44% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 6.53% |
| Float | 162.22M |
Valuation Ratios
The trailing PE ratio is 20.70 and the forward PE ratio is 19.80. SHA:603658's PEG ratio is 11.05.
| PE Ratio | 20.70 |
| Forward PE | 19.80 |
| PS Ratio | 5.04 |
| PB Ratio | 2.40 |
| P/TBV Ratio | 2.53 |
| P/FCF Ratio | 40.85 |
| P/OCF Ratio | 21.25 |
| PEG Ratio | 11.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.21, with an EV/FCF ratio of 38.23.
| EV / Earnings | 19.40 |
| EV / Sales | 4.72 |
| EV / EBITDA | 13.21 |
| EV / EBIT | 18.68 |
| EV / FCF | 38.23 |
Financial Position
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.45 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.06 |
| Interest Coverage | 117.20 |
Financial Efficiency
Return on equity (ROE) is 11.86% and return on invested capital (ROIC) is 14.75%.
| Return on Equity (ROE) | 11.86% |
| Return on Assets (ROA) | 5.69% |
| Return on Invested Capital (ROIC) | 14.75% |
| Return on Capital Employed (ROCE) | 11.06% |
| Weighted Average Cost of Capital (WACC) | 3.99% |
| Revenue Per Employee | 761,190 |
| Profits Per Employee | 185,192 |
| Employee Count | 5,700 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.36 |
Taxes
In the past 12 months, SHA:603658 has paid 131.66 million in taxes.
| Income Tax | 131.66M |
| Effective Tax Rate | 11.00% |
Stock Price Statistics
The stock price has decreased by -3.04% in the last 52 weeks. The beta is -0.05, so SHA:603658's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -3.04% |
| 50-Day Moving Average | 34.62 |
| 200-Day Moving Average | 33.87 |
| Relative Strength Index (RSI) | 60.49 |
| Average Volume (20 Days) | 6,492,797 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603658 had revenue of CNY 4.34 billion and earned 1.06 billion in profits. Earnings per share was 1.85.
| Revenue | 4.34B |
| Gross Profit | 2.92B |
| Operating Income | 1.10B |
| Pretax Income | 1.20B |
| Net Income | 1.06B |
| EBITDA | 1.54B |
| EBIT | 1.10B |
| Earnings Per Share (EPS) | 1.85 |
Balance Sheet
The company has 1.54 billion in cash and 32.73 million in debt, with a net cash position of 1.51 billion or 2.64 per share.
| Cash & Cash Equivalents | 1.54B |
| Total Debt | 32.73M |
| Net Cash | 1.51B |
| Net Cash Per Share | 2.64 |
| Equity (Book Value) | 9.12B |
| Book Value Per Share | 15.79 |
| Working Capital | 3.51B |
Cash Flow
In the last 12 months, operating cash flow was 1.03 billion and capital expenditures -494.23 million, giving a free cash flow of 535.72 million.
| Operating Cash Flow | 1.03B |
| Capital Expenditures | -494.23M |
| Depreciation & Amortization | 445.08M |
| Net Borrowing | 452.84M |
| Free Cash Flow | 535.72M |
| FCF Per Share | 0.94 |
Margins
Gross margin is 67.24%, with operating and profit margins of 25.27% and 24.33%.
| Gross Margin | 67.24% |
| Operating Margin | 25.27% |
| Pretax Margin | 27.59% |
| Profit Margin | 24.33% |
| EBITDA Margin | 35.53% |
| EBIT Margin | 25.27% |
| FCF Margin | 12.35% |
Dividends & Yields
This stock pays an annual dividend of 1.31, which amounts to a dividend yield of 3.42%.
| Dividend Per Share | 1.31 |
| Dividend Yield | 3.42% |
| Dividend Growth (YoY) | 3.97% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 71.11% |
| FCF Payout Ratio | 139.73% |
| Buyback Yield | 0.27% |
| Shareholder Yield | 3.69% |
| Earnings Yield | 4.83% |
| FCF Yield | 2.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for SHA:603658 is 40.21, which is 4.99% higher than the current price. The consensus rating is "Buy".
| Price Target | 40.21 |
| Price Target Difference | 4.99% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 10.20% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 27, 2021. It was a forward split with a ratio of 1.3.
| Last Split Date | May 27, 2021 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603658 has an Altman Z-Score of 5.26 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.26 |
| Piotroski F-Score | 4 |